Kenneth E. Goodman
Presidente en Israel Cancer Research Fund .
Perfil
Kenneth E.
Goodman is currently the Vice Chairman at Syracuse University and the Chairman at Israel Cancer Research Fund since 2012.
Previously, he worked as a Director at Forest Laboratories, Inc. from 1998 to 2011 and as a Senior Financial Officer at Wyeth LLC in 1980.
Mr. Goodman completed his undergraduate degree at The Martin J.
Whitman School of Management.
Cargos activos de Kenneth E. Goodman
| Empresas | Cargo | Inicio |
|---|---|---|
| Syracuse University | Director/Miembro de la Junta | - |
Israel Cancer Research Fund
 Israel Cancer Research Fund Investment Trusts/Mutual FundsMiscellaneous Israel Cancer Research Fund operates as a charitable organization. The non-profit company is based in New York, NY. | Presidente | - |
Antiguos cargos conocidos de Kenneth E. Goodman.
| Empresas | Cargo | Fin |
|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Director Financiero/CFO | 01/01/1980 |
| FOREST LABORATORIES, INC. | Director/Miembro de la Junta | - |
Formación de Kenneth E. Goodman.
| The Martin J. Whitman School of Management | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Israel Cancer Research Fund
Israel Cancer Research Fund Investment Trusts/Mutual FundsMiscellaneous Israel Cancer Research Fund operates as a charitable organization. The non-profit company is based in New York, NY. | Miscellaneous |
- Bolsa de valores
- Insiders
- Kenneth E. Goodman
